Kingsview Wealth Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History
Bought
Maintained
Sold
Other funds holding FBT
BFG
Kingsview Wealth Management's FBT Position: Q2 2026 in Review
Kingsview Wealth Management opened a new position in First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q2 2026: 2,182 shares worth $541K. The stake represents 0.01% of the portfolio and ranks #946 among its holdings. This is a return to the name: Kingsview Wealth Management previously reported a position in FBT as recently as Q1 2023.
Kingsview Wealth Management first reported a position in FBT in Q1 2017 and has held it in 18 quarters since. The position peaked at $3.03M in Q3 2018. 339 funds tracked by Wall St. Rank hold FBT as of Q2 2026.
- Kingsview Wealth Management held 2,182 shares of First Trust NYSE Arca Biotechnology Index Fund worth $541K as of Q2 2026.
- First Trust NYSE Arca Biotechnology Index Fund was a new Kingsview Wealth Management position in Q2 2026.
- First Trust NYSE Arca Biotechnology Index Fund made up 0.01% of Kingsview Wealth Management's portfolio in Q2 2026, its #946 holding.
- Kingsview Wealth Management first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2017 and has held it in 18 quarters since.
- Kingsview Wealth Management's First Trust NYSE Arca Biotechnology Index Fund position peaked at $3.03M in Q3 2018.
- 339 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.
Based on Kingsview Wealth Management's 13F filing for Q2 2026, filed 19 Aug 2026.